For that purpose, we performed an in vitro lysis assay using Pt#006-T cells as targets of pt#006 PRE, P1, P2, and P3 PBMC samples boosted in vitro either with the vaccine cells lysate, autologous tumor cells lysate or peptides that stimulated IFNγ production in the ELISPOT assays. The gene discussed is IFNG; the disease is neoplasm.